Keyphrases
Monoamine Oxidase B (MAO-B)
100%
1-Methyl
70%
Phenyl
58%
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
37%
South Africa
35%
Johannesburg
35%
3-Pyrrolines
30%
AIDS/HIV
28%
Phenylpyrroles
25%
Vmax
20%
Treatment Outcome
20%
Author Names
17%
Deuterium Isotope Effect
17%
Structure-activity Relationship
17%
Benzimidazole
17%
Neurotoxicity Screening
17%
Maternal Anemia
17%
In Vitro Quality
17%
Mining District
17%
Indium Complex
17%
Medical Applications
17%
3-azabicyclo[3.1.0]hexane
17%
3-methyl-1
17%
Commuter Population
17%
Monoamine Oxidase A (MAO-A)
17%
Persea Americana
17%
Avocado Oil
17%
Antiretroviral Therapy
17%
Clinical Trials
17%
Pediatric Tuberculosis
17%
Pregnant Women
17%
Meta-analysis
17%
Antibacterial Activity
17%
Unintended Pregnancy
17%
Pulmonary TB Patients
17%
Lesotho
17%
Inhibitory Activity
17%
Systematic Meta-analysis
17%
Rifampicin
17%
Enterococcus Faecium
17%
Enterococcus Faecalis
17%
Fixed-dose Combination
17%
Multiparticulates
17%
Scoping Review Protocol
17%
Caffeine
17%
Pyrazinamide
17%
Unfavorable Outcome
17%
Sub-Saharan Africa
17%
Tuberculosis Management
17%
Biological Applications
17%
Pharmacology, Toxicology and Pharmaceutical Science
Amine Oxidase (Flavin Containing) Isoenzyme B
82%
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
33%
Infection
26%
Hexane
23%
Structure Activity Relationship
20%
Disease
18%
Deuterium
17%
Benzimidazole
17%
Anemia
17%
Pyrazinamide
17%
Frailty
17%
Rifampicin
17%
Amine Oxidase (Flavin Containing)
17%
Avocado
17%
Lung Tuberculosis
17%
Adverse Drug Reaction
17%
Antibacterial Activity
17%
Pandemic
17%
Enterococcus faecalis
17%
Enterococcus faecium
17%
Clinical Trial
17%
Amine Oxidase (Flavin Containing) Isoenzyme A
11%
Phytochemical
11%
Antiinfective Agent
11%
Film Coating
8%
Solid Formulation
8%
Dosage Forms
8%
Pharmacotherapy
8%
Pharmacokinetics
8%
Drug Delivery System
8%
Bioavailability
8%
Tablet
8%
Intrinsic Clearance
7%
Neurotoxin
7%
Enzyme Inhibitor
7%
Competitive Inhibitor
7%
HIV
7%
Cytotoxicity
5%
Prevalence
5%
Cell Viability
5%
Drug Release
5%
Microscopy
5%
Excipient
5%
Monoamine
5%
Phenol
5%
Antimycobacterial Agent
5%
Mitochondrial Protein
5%
Lung Disease
5%
Enterococcus
5%
Immunomodulating Agent
5%